MEDEZE Welcomes Bumrungrad Executives, Showcasing World-Class Laboratory Capabilities to Drive Healthcare Innovation in Southeast Asia
Dr. Veerapol Khemarangsan Chief Executive Officer Ms. Danita Phithaknetikun, Chief Business Development Officer of MEDEZE Group Public Company Limited (“MEDEZE”), a leading provider of stem cell banking, hair follicle cell storage, and immune cell profiling services in Southeast Asia, warmly welcomed Associate Professor Dr. Polkrit Teekakeerikul, Chief Science Officer; Dr. Thanasit Techanukul, Deputy Head of Oncology and Director of Special Projects; and Ms. Wanalee Saksang, Nurse Manager of Preventive Genomics and Integrative Medicine at Bumrungrad International Hospital.
The visit, held at MEDEZE’s headquarters on Phutthamonthon Sai 4 Road, included a tour of the company’s internationally accredited laboratory and an in-depth exchange of technical knowledge on safety standards, preservation quality, and research and development. The engagement aimed to strengthen collaboration and advance the regional healthcare ecosystem.
IR Press Releases